Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid-Free vs Steroid-Containing Chemotherapy for NHL in HBV Carriers
NCT00262210Phase 2Completed
- Sponsor
- National Health Research Institutes
- Start
- Jun 1995
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of prednisolone, cyclophosphamide, epirubicin and etoposide in Non-Hodgkin lymphoma (NHL) (2 arms), sponsored by National Health Research Institutes. Primary endpoints: Incidence of HBV Reactivation and Incidence of Hepatitis Development. Started Jun 1995; status: completed.
02
Drugs
prednisolonecyclophosphamideepirubicinetoposide
03
Conditions
Non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00262210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262210.